Jump to main content
Jump to site search

A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards the therapy of breast cancer


Small interference RNA (siRNA) has demonstrated unprecedented potential as a therapy for drug-resistant cancer. However, efficient cellular delivery is still a challenge due to hydrolytic sensitivity and poor cellular uptake of siRNA. Strategies to conjugate siRNA to the delivery vehicle and activate innate immunity have shown low in vivo efficacy. Therefore, nanomedicine approaches have become the main focus in the field. B-cell lymphoma 2 (Bcl-2) is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inducing (pro-apoptotic) or inhibiting (anti-apoptotic) apoptosis. In this report, a nanomedicine system is constructed using Bcl-2 siRNA as the therapeutic agent and mesoporous polymer nanospheres (MPNs) carriers to both improve cellular internalization and achieve Bcl-2 silencing and cell apoptosis. MPNs were prepared through a two-stage hydrothermal processing at two different temperatures, which was deliberately designed to form nanospheres via self-assembly and create mesoporous structures by removing the pore-forming templates. Such MPNs were proved to be biodegradable. Without any carbonization process, MPNs still keep many active groups which endow them with excellent properties for functionalization purposes. Finally, the FA-targeted-Bcl-2-siRNA-loaded nanoparticles were constructed by a layer-by-layer assembly under electrostatic interactions after nitrification. These nanoparticles were efficiently delivered into breast cancer (BC) cells, showing a significant sequence-specific inhibition of Bcl-2 mRNA expression in BC cells, enhanced tumor cell apoptosis and tumor therapeutic efficacy. Taken together, this study establishes a novel therapeutic system for cancer therapy.

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Sep 2018, accepted on 04 Dec 2018 and first published on 05 Dec 2018

Article type: Paper
DOI: 10.1039/C8TB02463D
Citation: J. Mater. Chem. B, 2018, Accepted Manuscript
  •   Request permissions

    A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards the therapy of breast cancer

    X. Wu, Y. Zheng, D. Yang, T. Chen, B. Feng, J. Weng, J. Wang, K. Zhang and X. Zhang, J. Mater. Chem. B, 2018, Accepted Manuscript , DOI: 10.1039/C8TB02463D

Search articles by author